Generics 19

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Sacubitril manufacturers

19 products found

Filters

19 products found

sacubitril + valsartan

Tablets, film coated 24 mg + 26 mg ,49 mg + 51 mg ,97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Entresto®
Manufacturer #252

Manufacturer usually replies in 2 days

sacubitril + valsartan

Tablets, film coated 24 mg + 26 mg, 49 mg + 51 mg, 97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21467

Manufacturer usually replies in 4 days

sacubitril + valsartan

Tablets 24 mg + 26 mg, 49 mg + 51 mg, 97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q4 2025
Manufacturer #519

Manufacturer usually replies in 6 days

sacubitril + valsartan

Tablets, film coated 24 mg + 26 mg , 49 mg + 51 mg, 97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Entresto/Novartis
Manufacturer #15925
The global pharmaceutical manufacturer that deals with affordable but high-quality drugs that help in getting exceptional aftercare services in terms of pharmaceutical products. Their products are innovated and made at the lab and then completely tested so that the best results could be achieved.

Manufacturer usually replies in 8 days

sacubitril + valsartan

Tablets 24 mg + 26 mg, 49 mg + 51 mg, 97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q1 2024
Manufacturer #17047
A pharmaceutical manufacturer based in the EU that sells its products in Europe, the Middle East, CIS, LATAM, and Asia. Key production lines are pharmaceuticals, bio and nanopharmaceuticals, medical devices, and nutraceuticals. The main therapeutic area is oncology.

Manufacturer usually replies in 10 days

sacubitril + valsartan

Tablets, film coated 24 mg + 26 mg ,49 mg + 51 mg ,97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

sacubitril + valsartan

Tablets, film coated 24 mg/26 mg, 49 mg/51 mg , 97 mg/103 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Panama , Vietnam
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

sacubitril + valsartan

Tablets 24 mg + 26 mg ,49 mg + 51 mg ,97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #10627

Manufacturer usually replies in 9 days

sacubitril + valsartan

Tablets 24 mg + 26 mg ,49 mg + 51 mg ,97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #21496

It's a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 8 days

sacubitril + valsartan

Tablets 24 mg + 26 mg, 49 mg + 51 mg, 97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #13095

Manufacturer usually replies in 5 days

sacubitril + valsartan

Tablets 24 mg + 26 mg, 48.6 mg + 51.4 mg, 49 mg + 51 mg ,97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #18975

Manufacturer usually replies in 6 days

sacubitril + valsartan

Tablets 24 mg + 26 mg, 49 mg + 51 mg, 97 mg + 103 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
FDA, EU GMP
Manufacturer #21340

Manufacturer usually replies in 9 days

sacubitril + valsartan

Tablets 24 mg + 26 mg ,49 mg + 51 mg ,97 mg + 103 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 4 days

sacubitril + valsartan

Tablets 24 mg + 26 mg, 49 mg + 51 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21084

Manufacturer usually replies in 5 days

sacubitril + valsartan

Tablets 49 mg + 51 mg, 24 mg + 26 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20259

Manufacturer usually replies in 9 days

sacubitril + valsartan

Tablets, immediate release (IR) 24 mg + 26 mg, 49 mg + 51 mg, 97 mg + 103 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA, EU GMP, WHO, MHRA
Manufacturer #16394

Manufacturer usually replies in 13 days

sacubitril + valsartan

Tablets, immediate release (IR) 24 mg + 26 mg, 49 mg + 51 mg, 97 mg + 103 mg

Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA, Canada
Manufacturer #16394

Manufacturer usually replies in 13 days

sacubitril + valsartan

Tablets 24 mg+26 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19820

Manufacturer usually replies in 11 days

valsartan + sacubitril

Tablets, film coated 50 mg, 100 mg, 200 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Ukraine
GMP approvals
EU GMP
Comments
Dossier availability date: Q3 2025
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

SACUBITRIL Manufacturers

Sacubitril is a medical substance also known as neprilysin inhibitor that is used in combination with valsartan as an aide to decrease the chance of cardiovascular passing and hospitalization for heart disappointment in patients with incessant heart disappointment (NYHA Course II-IV) and diminished discharge division. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking SACUBITRIL: You should not use This medical remedy if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide.

How does SACUBITRIL work?

Sacubitril's dynamic metabolite, LBQ657 hinders neprilysin, an unbiased endopeptidase that would regularly cleave natriuretic peptides, which incorporate: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and c-type natriuretic peptide (CNP).

The Wholesale Price of SACUBITRIL

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The cost for SACUBITRIL oral tablet (24 mg-26 mg) is around $618 for a supply of 60 tablets. Prices may vary on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of SACUBITRIL offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for SACUBITRIL manufacturers and SACUBITRIL suppliers that you are looking for. These also enable you to check the dossier status of Valaciclovir, and the GMP approvals of the different variants of Valaciclovir. Also, each manufacturer or supplier product description contains essential information about SACUBITRIL including clinical data, stability zones, countries where SACUBITRIL is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.